Removal of selected pharmaceuticals from domestic wastewater in an activated sludge system followed by a horizontal subsurface flow bed - Analysis of their respective contributions

Science of the Total Environment

Volumn 454-455, Issue , 2013, Pages 411-425

  Verlicchi, P ^a   Galletti, A ^b   Petrovic, M ^c,d   Barcelo D ^d,e   Al Aukidy, M ^a   Zambello, E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b CH2M HILL ^*  (Italy)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

^e INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Activated sludge system; Domestic wastewaters; Horizontal subsurface flow bed; Mass loadings; Pharmaceuticals; Removal efficiencies

Indexed keywords

ACTIVATED SLUDGE SYSTEMS; DOMESTIC WASTEWATER; HORIZONTAL SUBSURFACE FLOW; MASS LOADINGS; REMOVAL EFFICIENCIES;

DRUG PRODUCTS; PILOT PLANTS; REMOVAL; WETLANDS;

EFFLUENTS;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; RECEPTOR BLOCKING AGENT;

ACTIVATED SLUDGE; CONSTRUCTED WETLAND; DOMESTIC WASTE; DRUG; POLLUTANT REMOVAL; WASTEWATER;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; ARTICLE; CONTROLLED STUDY; DOMESTIC WASTE; EFFLUENT; ENVIRONMENTAL PROTECTION; ITALY; LIMIT OF DETECTION; POLLUTANT; PRIORITY JOURNAL; RIVER; SAMPLING; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WETLAND;

ITALY; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WETLANDS;

ITALY;

EID: 84876333959     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.03.044     Document Type: Article

References (113)

1. Acero J.L., Javier Benitez F., Real F.J., Roldan G. Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices. Water Res 2010, 44:4158-4170.
2. Al Aukidy M., Verlicchi P., Jelic A., Petrovic M., Barcelò D. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po valley, Italy. Sci Total Environ 2012, 438:15-25.
3. Alder A.C., Schaffner C., Majewsky M., Klasmeier J., Fenner K. Fate of β-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res 2010, 44:936-948.
4. Andreozzi R., Canterino M., Marotta R., Paxéus N. Antibiotic removal from wastewaters: the ozonation of amoxicillin. J Hazard Mater 2005, 122:243-250.
5. Ávila C., Pedescoll A., Matamoros V., Bayona J.M., García J. Capacity of a horizontal subsurface flow constructed wetland system for the removal of emerging pollutants: an injection experiment. Chemosphere 2010, 81:1137-1142.
6. Ávila C., Reyes C., Bayona J.M., García J. Emerging organic contaminant removal depending on primary treatment and operational strategy in horizontal subsurface flow constructed wetlands: influence of redox. Water Res 2013, 47:315-325.
7. Batt A.L., Kim S., Aga D.S. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge. Environ Sci Technol 2006, 40:7367-7373.
8. Beier S., Cramer C., Koster S., Mauer C., Palmowski L., Schroder H.F., et al. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci Technol 2011, 63:66-71.
9. Bendz D., Paxéus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, case study: Hoje River in Sweden. J Hazard Mater 2005, 122:195-204.
10. Benitez F.J., Acero J.L., Real F.J., Roldan G., Casas F. Comparison of different chemical oxidation treatments for the removal of selected pharmaceuticals in water matrices. Chem Eng J 2011, 168:1149-1156.
11. Brimecombe M.J., Leij F.A.A.M., Lynch J.M. Rhizodeposition and microbial populations. The Rhizosphere: Biogeochemistry and organic Substrates at the Soil-plant Interface 2001, 74-98. Marcel Dekker, New York. R. Pinton, Z. Varanini, P. Nannipieri (Eds.).
12. Brown K.D., Kulis J., Thomson B., Chapman T.H., Mawhinney D.B. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci Total Environ 2006, 366:772-783.
13. Carballa M., Omil F., Lema J.M., Liompart M., Garcia-Jares C., Rodriguez I., et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 2004, 38:2918-2926.
14. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40:357-363.
15. Choi K., Kim Y., Park J., Park C., Kim M., Kim S., et al. Seasonal variation of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci Total Environ 2008, 405:120-128.
16. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 2005, 39:97-106.
17. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 2005, 39:4797-4807.
18. Coetsier C.M., Spinelli S., Lin L., Roig B., Touraud E. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?. Environ Int 2009, 35:787-792.
19. Conkle J.L., White J.R., Metcalfe C.D. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 2008, 73:1741-1748.
20. Costanzo S.D., Murby J., Bates J. Ecosystem response to antibiotics entering the aquatic environment. Mar Pollut Bull 2005, 51:218-223.
21. Daughton C.G., Ruhoy I.S. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ Toxicol Chem 2009, 28:2459-2521.
22. De Voogt P., Janex-Habibni M.L., Sacher F., Puijker L., Mons M. Development of a common priority list of pharmaceuticals relevant for water cycle. Water Sci Technol 2009, 59:39-46.
23. Decreto legislativo 152/2006. Norme in materia ambientale.
24. Dougherty J.A., Swarzenski P.W., Dinicola R.S., Reinhard M. Occurrence of herbicides and pharmaceutical and personal care products in surface water and groundwater around Liberty Bay, Puget Sound, Washington. J Environ Qual 2010, 39:1173-1180.
25. European Community (EC) Directive of the European Parliament and of the Council amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy, COM(876) final, 2011/0429 (COD) draft 31.1.2012 2012.
26. Foster AL. Occurrence and fate of endocrine disruptors through the San Marco Wastewater treatment plant, Thesis of Master of Science, Texas State University. 2007.
27. García-Galán M.J., Díaz-Cruz M.S., Barceló D. Occurrence of sulfonamide residues along the Ebro River basin. Removal in wastewater treatment plants and environmental impact assessment. Environ Int 2011, 37:462-473.
28. Ghosh G.C., Okuda T., Yamashita N., Tanaka H. Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation. Water Sci Technol 2009, 59:779-786.
29. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 2005, 39:3981-3989.
30. Göbel A., Mcardell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprime in different wastewater treatment technologies. Sci Total Environ 2007, 372:361-371.
31. Golet E., Xifra I., Siegrist H., Alder A., Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ Sci Technol 2003, 37:3243-3249.
32. Gómez M.J., Martinez Bueno M.J., Lacorte S., Fernandez-Alba A.R., Aguera A. Pilot survey monitoring pharmaceuticals and related compounds in sewage treatment plant located on the Mediterranean cost. Chemosphere 2007, 66:993-1002.
33. Gros M., Petrovic M., Barcelò D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009, 81:898-912.
34. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 2010, 36:15-26.
35. Gruppo di lavoro OsMed L'uso dei farmaci in Italia. Rapporto nazionale anno 2010 2011, Il Pensiero Scientifico Editore, Roma, [(in Italian), available at the web site: www.agenziafarmaco.it (last access on January 8th 2013)].
36. Gulkowska A., Leung H.W., So M.K., Taniyasu S., Yamashita N., Yeung L.W.Y., et al. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Res 2008, 42:395-403.
37. Hijosa-Valsero M., Matamoros V., Martin-Villacorta J., Becares E., Bayona J.M. Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Res 2010, 44:1429-1439.
38. Hijosa-Valsero M., Matamoros V., Sidrach-Cardona R., Martin-Villacorta J., Becares E., Bayona J.M. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters. Water Res 2010, 44:3669-3678.
39. Hijosa-Valsero M., Matamoros V., Pedescoll A., Martín-Villacorta J., Bécares E., García J., et al. Evaluation of primary treatment and loading regimes in the removal of pharmaceuticals and personal care products from urban wastewaters by subsurface-flow constructed wetlands. Int J Environ Anal Chem 2011, 91:632-653.
40. Hijosa-Valsero M., Matamoros V., Sidrach-Cardona R., Pedescoll A., Martín-Villacorta J., García J., et al. Influence of design, physico-chemical and environmental parameters on pharmaceuticals and fragrances removal by constructed wetlands. Water Sci Technol 2011, 63:2527-2534.
41. Hollender J., Zimmermann S.G., Koepke S., Krauss M., McArdell C.S., Ort C., et al. Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ Sci Technol 2009, 43:7862-7869.
42. IAWR International Association of Waterworks in the Rhine catchment area Danube, Meuse and Rhine - memorandum 2008, 1-20.
43. Imfeld G., Braeckevelt M., Kuschk P., Richnow H.H. Review: monitoring and assessing processes of organic chemicals removal inonstructed wetlands. Chemosphere 2009, 74:349-362.
44. Jones O.A.H., Voulvoulis N., Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environ Pollut 2007, 145:738-744.
45. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 2006, 40:1686-1696.
46. Karthikeyan K.G., Meyer M.T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Sci Total Environ 2006, 361:196-207.
47. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 2009, 43:363-380.
48. Khan S.J., Ongerth J.E. Occurrence and removal of pharmaceuticals at an Australian sewage treatment plant. Water 2005, 35-39.
49. Kim S., Cho J., Kim I., Vanderford B., Snyder S. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and wastewaters. Water Res 2007, 41:1013-1021.
50. Kimura K., Hara H., Watanabe Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 2005, 178:135-140.
51. Kimura K., Hara H., Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 2007, 41:3708-3714.
52. Kleywegt S., Pileggi V., Yang P., Hao C., Zhao X., Rocks C., et al. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada - occurrence and treatment efficiency. Sci Total Environ 2011, 409:1481-1488.
53. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J Environ Manage 2009, 90:2354-2366.
54. Li B., Zhang T. Mass flows and removal of antibiotics in two municipal wastewater treatment plants. Chemosphere 2011, 83:1284-1289.
55. Lindberg R., Wennberg P., Johansson M., Tysklind M., Andersson B. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ Sci Technol 2005, 39:3421-3429.
56. Lindberg R.H., Olofsson U., Rendahl P., Johansson M.I., Tysklind M., Andersson B.A.V. Behavior of fluoroquinolones and trimethoprime during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. Environ Sci Technol 2006, 40:1042-1048.
57. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewage and in receiving waters. Water Res 2005, 39:2219-2228.
58. Lipp P., Gross H.G., Tiehm A. Improved elimination of organic micropollutants by a process combination of membrane bioreactor (MBR) and powdered activated carbon (PAC). Desalin Water Treat 2012, 42:65-72.
59. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 2006, 367:544-558.
60. Llorens E., Matamoros V., Domingo V., Bayona J.M., García J. Water quality improvement in a full-scale tertiary constructed wetland: effects on conventional and specific organic contaminants. Sci Total Environ 2009, 407:2517-2524.
61. Matamoros V., Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ Sci Technol 2006, 40:5811-5816.
62. Matamoros V., Garcia J., Bayona J.M. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environ Sci Technol 2005, 39:5449-5454.
63. Matamoros V., Arias C., Brix H., Bayona J.M. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and sand filter. Environ Sci Technol 2007, 41:8171-8177.
64. Matamoros V., Caselles-Osorio A., Garcia J., Bayona J.M. Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment. Sci Total Environ 2008, 394:171-176.
65. Matamoros V., Garcia J., Bayona J.M. Organic micropollutant removal in a full scale surface flow constructed wetland fed with secondary effluent. Water Res 2008, 42:653-660.
66. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., et al. Antidepressants and their metabolites in municipal wastewater and downstream exposure in an urban watershed. Environ Technol Chem 2010, 29:79-89.
67. Michael I., Rizzo L., McArdell C.S., Manaia C.M., Merlin C., Schwartz T., et al. Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review. Water Res 2013, 47:957-995.
68. Muñoz I., Gómez-Ramos M.J., Agüera A., García-Reyes J.F., Molina-Díaz A., Fernández-Alba A.R. Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture. Trends Anal Chem 2009, 28:676-694.
69. Muñoz I., López-Doval J.C., Ricart M., Villagrasa M., Brix R., Geiszinger A., et al. Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat river basin (Northeast Spain). Environ Toxicol Chem 2009, 28:2706-2714.
70. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 2006, 40:3297-3303.
71. Park N., Vanderford B., Snyder S.A., Sarp S., Kim S.D., Cho J. Effective controls of micropollutants included in wastewater effluent using constructed wetlands under anoxic condition. Ecol Eng 2009, 35:418-423.
72. Paxéus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprime and triclosan in conventional wastewater treatment plants in EU countries and their discharge to the aquatic environment. Water Sci Technol 2004, 50:253-260.
73. Peng X., Wang Z., Kuang W., Tan J., Li K. A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewater of two sewage treatment plants in Guangzhou, China. Sci Total Environ 2006, 371:314-322.
74. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 2005, 39:2654-2664.
75. Radjenovic J., Petrovic M., Barceló D. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 2007, 387:1365-1377.
76. Radjenovic J., Petrovic M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor(MBR) treatment. Water Res 2009, 43:831-841.
77. Ranieri E., Verlicchi P., Young T.M. Paracetamol removal in subsurface flow constructed wetlands. J Hydrol 2011, 404:130-135.
78. Richardson S.D., Ternes T. Water analysis: emerging contaminants and current issues. Anal Chem 2011, 83:4614-4648.
79. Rimkus G.G. Polycyclic musk fragrances in aquatic environment. Toxicol Lett 1999, 111:37-56.
80. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 2006, 356:143-153.
81. Rodriguez I., Quintana J.B., Carpinterio J., Carro A.M., Lorenzo R.A., Cela R. Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tert-butyldimethylsilyl derivatives. J Chromatogr A 2003, 985:265-274.
82. Rosal R., Rodrìguez A., Perdigòn-Melòn J.A., Petre A., Garcìa-Calvo E., Gòmez M.J., et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 2010, 44:578-588.
83. Rúa-Gómez P.C., Püttmann W. Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater. J Environ Monitor 2012, 14:1391-1399.
84. Ruel S.M., Esperanza M., Choubert J.M., Valor I., Budzinski H., Coquery M. On-site evaluation of the efficiency of conventional and advanced secondary processes for the removal of 60 organic micropollutants. Water Sci Technol 2010, 62:2970-2978.
85. Ruhoy I.S., Daughton C.G. Beyond the medicine cabinet: an analysis of where and why medications accumulate. Environ Int 2008, 34:1157-1169.
86. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 2007, 33:596-601.
87. Santos J.L., Aparicio I., Callejon M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewater from four wastewater treatment plants in Seville (Spain). J Hazard Mater 2009, 164:1509-1516.
88. Schwarzenbach R.P., Gschwend P.M., Imboden D.M. Environmental organic chemistry 2003, Wiley-Interscience, New York.
89. Stottmeister U., Wießner A., Kuschk P., Kappelmeyer U., Kastner M., Bederski O., et al. Effects of plants and microorganisms in constructed wetlands for wastewater treatment. Biotechnol Adv 2003, 22:93-117.
90. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drugs residues in sewage and natural waters in the state of Rio De Janeiro, Brazil. Sci Total Environ 1999, 225:135-141.
91. Suárez S., Ramil M., Omil F., Lema J.M. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants. Water Sci Technol 2005, 52:9-14.
92. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39:1761-1772.
93. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
94. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., et al. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrancies from wastewaters?. Water Res 2003, 37:1976-1982.
95. Thomas P.M., Foster G.D. Tracking acidic pharmaceutical, caffeine, and triclosan through the wastewater treatment process. Environ Technol Chem 2005, 24:25-30.
96. Public drinking water supply - evaluation of organic micropollutants. Letter to the Ministry of the Environment and Conservation, Agriculture and Consumer Protection of the state of North Rhine-Westphalia from March 14th 2008, UBA The Federal Environment Agency (Ed.).
97. Verlicchi P., Galletti A., Masotti L. A promising practice to reclaim treated wastewater for reuse: chemical disinfection followed by natural systems. Desalination 2009, 247:490-508.
98. Verlicchi P., Galletti A., Masotti L. Management of hospital wastewaters: the case of the effluent of a large hospital situated in a small town. Water Sci Technol 2010, 61:2507-2519.
99. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 2012, 430:409-418.
100. Verlicchi P., Al Aukidy M., Galletti A., Zambello E., Zanni G., Masotti L. A project of reuse of reclaimed wastewater in the Po Valley, Italy: polishing sequence and cost benefit analysis. J Hydrol 2012, 432-433:127-136.
101. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci Total Environ 2012, 429:123-155.
102. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 93:8220-8226.
103. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 41:1001-1012.
104. Watkinson A.J., Murby E.J., Costanzo S.D. Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water Res 2007, 41:4164-4174.
105. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
106. Wick A., Fink G., Siegriest H., Ternes T.A. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. Water Res 2009, 43:1060-1074.
107. Xu W.H., Zhang G., Li X.D., Zou S.C., Li P., Hu Z.H., et al. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), south China. Water Res 2007, 41:4526-4534.
108. Yu J.T., Bouwer E.J., Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric Water Manag 2006, 86:72-80.
109. Yasojima M., Nakada N., Komori K., Suzuki Y., Tanaka H. Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water Sci Technol 2006, 53:227-233.
110. Zhang D.Q., Gersberg R.M., Hua T., Zhu J., Tuan N.A., Tan S.K. Pharmaceutical removal in tropical subsurface flow constructed wetlands at varying hydraulic loading rates. Chemosphere 2012, 87:273-277.
111. Zorita S., Martensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 2009, 407:2760-2770.
112. Zwiener C., Frimmel F.H. Oxidative treatment of pharmaceuticals in water. Water Res 2000, 34:1881-1885.
113. Zwiener C., Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen and diclofenac. Sci Total Environ 2003, 309:201-211.